To: jhild who wrote (982 ) 11/30/1998 1:22:00 PM From: Liberty Capital Read Replies (4) | Respond to of 1286
To refresh your memory, this is what you posted: From post 947, Jhild asked: "And we are to take from this then that VirusShield is the product that is being repackaged by NBMX as SafeShield, since this appears to be the product tested in that report?" From post 973, Liberty Capital stated: "VirusShield and SafeShield are the same product owned by National Boston. There was a name change from VirusShield to SafeShield." Regarding your post #977: "Hey Bub, that wasn't the question. So for refreshers, how about straightening out this tangle of corporations. The public still awaits an explanation of the ownership/relationship of: Growth Industries Fragrance Express BonTempi Medical Exclusive Cruises Suxess Travel Delta Vacation Properties National Boston Medical SeaBridge Shipping" Jhild: Although we do not feel compelled to respond to your disrespectful babble on this board, and will not if future posts continue to disrespect Liberty Capital, here is the answer to your question: Growth Industries, Fragrance Express, Exclusive Cruises, Suxess Travel, Delta Vacation Properties, and Seabridge Shipping are all FGRX acquisitions. We do not represent FGRX. Perhaps FGRX management can answer your questions regarding these companies. We have passed on your inquiries. BonTempi Medical is a subsidiary of NBMX that controls Canadian and U.S. distribution rights for the BonTempi Line of products. There are two corporations for NBMX and we are getting details on the relationship between these two corporations. We hope to have a graph up on our website (http://www.libertycap.com) explaining this relationship by the end of December. Liberty Capital Group, Inc. research@libertycap.comlibertycap.com ______________________________________________________________________ This information is not a solicitation to buy or sell securities. Investors should always consult a registered investment advisor before making any investment decisions. Liberty Capital Group (LCG) picked National Boston ("the Company") due to the tremendous growth potential in the market for antibacterial products. Additionally, LCG feels that the alliances the Company has developed over the last few months will help propel National Boston to a large and sustained revenue stream. Due to the above, LCG has agreed to a contract with National Boston as their financial and public relations firm. LCG's contract is a full one year term and will include fees and cash of between $732,000 - $756,000. Due to huge market potential, LCG has agreed to invest up to $500,000 through an option, with prices scaled from $1.00/sh - $7.00/sh.